Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma

  title={Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma},
  author={Sergio P. A. Toledo and Delmar Muniz Lourenço and Marcelo Augusto Santos and Marcos Tavares and Rodrigo de Toledo and Joya Emilie de Menezes Correia-Deur},
Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid carcinoma. Currently, calcitonin measurements are mostly useful in the evaluation of tumor size and progression, and as an index of biochemical improvement of medullary thyroid carcinomas. Although measurement of calcitonin is a highly sensitive method for the detection of medullary thyroid carcinoma, it presents a low specificity for this tumor. Several physiologic and pathologic conditions other than medullary… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 38 extracted citations


Publications referenced by this paper.
Showing 1-10 of 52 references

Editorial: Calcitonin determination in patients with nodular thyroid disease.

The Journal of clinical endocrinology and metabolism • 2007
View 8 Excerpts
Highly Influenced

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

The Journal of clinical endocrinology and metabolism • 2001
View 20 Excerpts
Highly Influenced

[Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke • 2000
View 12 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…